Home › NDC Lookup › RxCUI directory › RxCUI 2703048

2 ML mirikizumab-mrkz 100 MG/ML Prefilled Syringe [Omvoh] — RxCUI 2703048

Name: 2 ML mirikizumab-mrkz 100 MG/ML Prefilled Syringe [Omvoh] (RxCUI 2703048)
Creator: Brian Staiger, PharmD

RxNorm drug concept · Semantic branded drug

RxCUI 2703048 Semantic branded drug · SBD ● Current RxNorm concept 7 FDA products 10 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by Dr. Brian Staiger, PharmD

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI2703048

Official name2 ML mirikizumab-mrkz 100 MG/ML Prefilled Syringe [Omvoh]

Concept typeSemantic branded drug (SBD)

RxNorm statusCurrent RxNorm concept

Also known as2 ML Omvoh 100 MG/ML Prefilled Syringe; omvoh 200 MG in 2 ML Prefilled Syringe; Omvoh 200 MG per 2 ML Prefilled Syringe

FDA products mapped7

Package NDCs mapped10

Reported Medicaid activity (SDUD)123 prescriptions · 3 state & territory Medicaid programs · latest period Q4 2025

RxNorm release07/06/2026

Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Mirikizumab-Mrkz: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist

Omvoh is a biologic medication — a lab-engineered protein that targets a very specific part of your immune system called IL-23. IL-23 is a signaling molecule that drives the gut in...
What exactly is Omvoh and how is it different from other IBD treatments?
No — only at the start. The first three doses are intravenous infusions given at a clinic at Weeks 0, 4, and 8. After that, starting at Week 12, you switch to subcutaneous injectio...
Do I have to keep going to the clinic for infusions the whole time?

📖 Read our full Mirikizumab-Mrkz guide →

🕸️ Concept Web — How 2 ML mirikizumab-mrkz 100 MG/ML Prefilled Syring... Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.

This page's concept 2 ML mirikizumab-mrkz 100 MG/ML Prefilled Syringe [Omvoh] RxCUI 2703048 Semantic branded drug · SBD

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

Ingredients 2

The active substance itself — no strength, form, or brand attached yet.
- Mirikizumab 2668384 IN
- Mirikizumab-mrkz 2668385 PIN
Brand names 1

The same medicine's trade names. A brand name alone says nothing about strength or form.
- Omvoh 2668393 BN
Dose forms 9

The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
- Mirikizumab Prefilled Syringe 2680726 SCDF
- Mirikizumab-mrkz Prefilled Syringe 2680727 SCDFP
- Mirikizumab Injectable Product 2668387 SCDG
- Mirikizumab-mrkz Injectable Product 2668389 SCDGP
- Mirikizumab Prefilled Syringe [Omvoh] 2680730 SBDF
- Mirikizumab-mrkz Prefilled Syringe [Omvoh] 2680731 SBDFP
- Omvoh Injectable Product 2668395 SBDG
- Prefilled Syringe 721656 DF
- +1 more in this family
Clinical & branded drugs 3

Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
- 2 ML mirikizumab-mrkz 100 MG/ML Prefilled Syringe 2703047 SCD
- Mirikizumab-mrkz 100 MG/ML 2668402 SCDC
- Mirikizumab-mrkz 100 MG/ML [Omvoh] 2668407 SBDC
Packs 2

Fixed collections of drugs packaged and sold together, like dose packs.
- {1 (1 ML mirikizumab-mrkz 100 MG/ML Prefilled Syringe [Omvoh]) / 1 (2 ML mirikizumab-mrkz 100 MG/ML Prefilled Syringe [Omvoh]) } Pack [Omvoh Prefilled Syringe 300 MG Dose Carton] 2703054 BPCK
- {1 (1 ML mirikizumab-mrkz 100 MG/ML Prefilled Syringe) / 1 (2 ML mirikizumab-mrkz 100 MG/ML Prefilled Syringe) } Pack 2703053 GPCK

Showing up to 8 concepts per family — 16 of 17 stored related concepts drawn.

These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

2 ML mirikizumab-mrkz 100 MG/ML Prefilled Syringe SCD · 2703047
{1 (1 ML mirikizumab-mrkz 100 MG/ML Prefilled Syringe) / 1 (2 ML mirikizumab-mrkz 100 MG/ML Prefilled Syringe) } Pack GPCK · 2703053
Mirikizumab-mrkz 100 MG/ML SCDC · 2668402
Mirikizumab Prefilled Syringe SCDF · 2680726
Mirikizumab-mrkz Prefilled Syringe SCDFP · 2680727
Mirikizumab Injectable Product SCDG · 2668387
Mirikizumab-mrkz Injectable Product SCDGP · 2668389

Brand-Name Concepts

{1 (1 ML mirikizumab-mrkz 100 MG/ML Prefilled Syringe [Omvoh]) / 1 (2 ML mirikizumab-mrkz 100 MG/ML Prefilled Syringe [Omvoh]) } Pack [Omvoh Prefilled Syringe 300 MG Dose Carton] BPCK · 2703054
Mirikizumab-mrkz 100 MG/ML [Omvoh] SBDC · 2668407
Mirikizumab Prefilled Syringe [Omvoh] SBDF · 2680730
Mirikizumab-mrkz Prefilled Syringe [Omvoh] SBDFP · 2680731
Omvoh Injectable Product SBDG · 2668395
Omvoh BN · 2668393

📦 FDA Products & Package NDCs

7 products · 10 package NDCs

10 package NDCs map to RxCUI 2703048 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.

Package NDC	Package	Brand / generic name	Labeler	Marketing start
00002-1442-11	1 SYRINGE in 1 CARTON (0002-1442-11) / 2 mL in 1 SYRINGE (0...	Omvoh	Eli Lilly and Company	2025-10-23
00002-3116-11	1 SYRINGE in 1 CARTON (0002-3116-11) / 2 mL in 1 SYRINGE (0...	Omvoh	Eli Lilly and Company	2025-10-23
00002-3116-61	1 SYRINGE in 1 CARTON (0002-3116-61) / 2 mL in 1 SYRINGE	Omvoh	Eli Lilly and Company	2025-11-06
00002-7575-01	1 VIAL, SINGLE-DOSE in 1 CARTON (0002-7575-01) / 15 mL in 1...	Omvoh	Eli Lilly and Company	2023-10-26
00002-7717-11	1 KIT in 1 CARTON (0002-7717-11) * 1 mL in 1 SYRINGE * 2...	Omvoh	Eli Lilly and Company	2025-01-15
00002-7717-61	1 KIT in 1 CARTON (0002-7717-61) * 1 mL in 1 SYRINGE * 2...	Omvoh	Eli Lilly and Company	2025-01-15
00002-7722-11	1 KIT in 1 CARTON (0002-7722-11) * 1 mL in 1 SYRINGE (0002...	Omvoh	Eli Lilly and Company	2025-01-15
00002-8011-27	2 SYRINGE in 1 CARTON (0002-8011-27) / 1 mL in 1 SYRINGE (0...	Omvoh	Eli Lilly and Company	2023-10-26
00002-8011-61	2 SYRINGE in 1 CARTON (0002-8011-61) / 1 mL in 1 SYRINGE	Omvoh	Eli Lilly and Company	2024-01-16
00002-8870-27	2 SYRINGE in 1 CARTON (0002-8870-27) / 1 mL in 1 SYRINGE (0...	Omvoh	Eli Lilly and Company	2024-04-29

Observed labelers: Eli Lilly and Company (10) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🧾 Billing Codes (HCPCS)

Medical billing codes (HCPCS "J-codes") that connect to this concept's packages — used mostly when a clinic or hospital bills for a drug it administers. Each code links to its full billing page.

Code	Descriptor	Mapped packages	Sources
J2267	Inj, mirikizumab-mrkz, 1 mg	7	CMS

⚠ A crosswalk is not coverage: an NDC↔HCPCS mapping does not guarantee any payer covers or pays the code. Always verify the current payer policy before billing.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7

openFDA export observedJul 14, 2026

RxNorm release07/06/2026

Methodology2026-07-full-catalog-v1

A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.

This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.